|
 |
||||
 |
|
|
|
||
|
Rosetta Inpharmatics, Inc. – Realized Rosetta Inpharmatics, a developer of new technologies for drug discovery that allow high-throughput screening of potential therapeutic compounds for their effects on cells, was sold to Merck in May 2001.
|
|||||
© 2001-06 PERSEUS, L.L.C., Designer: Beebe Communications, Inc. — Site updated |
|||||
